Sept-Oct 1983 The Use of 2-0xazolidinone as a Latent Aziridine Equivalent. I. A Facile Method for the Preparation of 2-Substituted Oxazolines Graham S. Poindexter Preclinical Cardiovascular Research, Pharmaceutical Research and Development Division, Bristol-Myers Company,